ChromaDex Stock Forum

$Trinity Biotech (TRIB.US)$ $Wag! Group (PET.US)$ $Ohmyhome (OMH.US)$ $Edesa Biotech (EDSA.US)$ $Tian Ruixiang (TIRX.US)$ $ChromaDex (CDXC.US)$ $Atlassian (TEAM.US)$ $ZW Data Action Tech (CNET.US)$ $Phoenix Motor (PEV.US)$ $Athira (ATHA.US)$ $Theriva Biologics (TOVX.US)$ $Pro-Dex (PDEX.US)$ $VS MEDIA Holdings (VSME.US)$
📊⚡️📊

$ChromaDex (CDXC.US)$
ChromaDex Corporation Reports Third Quarter 2024 Financial Results
Total net sales of $25.6 million, up $6.1 million or 31% year-over-year, gross margin of 63.5% and record net income and adjusted EBITDA of $1.9 million and $2.9 million, respectively, for the three months ended September 30, 2024
ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the third quarter of 2024.
Third Quarter 2024 Financial and Recent Operational Highlights
Total net s...

Oh, no, numbers did a thing!!!! PAN8C SELL
Anticipating rate cuts in September, businesses increased payrolls by re-hiring all the people they laid off earlier in the year or later to "protect margins."
Why wouldn't you try to get a head start on boosted demand for products?
Predictably, Old Money doesn't think past the week, so if nothing else, next week, will present entry points.
$ChromaDex (CDXC.US)$ Bioscience, aging products.
FY24 Estimates:
Sales growth +13% yoy
Gross marg...

$ChromaDex (CDXC.US)$
ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics
ChromaDex Corp. (NASDAQ:CDXC) has announced the expansion of its pharmaceutical-grade Niagen® (nicotinamide riboside chloride) IV and injection offerings to 14 additional leading wellness clinics across the United States. This follows the successful debut of quantities in select clinics last month. Wells Pharma of Houston, a U.S. FDA-registered ...

$ChromaDex (CDXC.US)$
ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+
ChromaDex Corp. (NASDAQ:CDXC) has secured U.S. Patent number 10,000,520 C1 for the composition of matter of salt forms of NMNH (dihydronicotinamide mononucleotide), a precursor to NAD+. This patent, co-owned with Queen's University Belfast, grants ChromaDex exclusive rights to the disodium salt form of NMNH. The company now has over ...

$ChromaDex (CDXC.US)$
ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August
ChromaDex Corp. (NASDAQ:CDXC) announces the debut of pharmaceutical-grade Niagen® (nicotinamide riboside chloride) for intravenous and injectable use at leading wellness clinics in August. Wells Pharma of Houston, a U.S. FDA-registered 503B outsourcing facility, will compound and distribute Niagen+ to select IV clinics.
Niagen IV offers superior t...

$ChromaDex (CDXC.US)$
NEWS
ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement

$ChromaDex (CDXC.US)$ 👀 can this 12 ?

$ChromaDex (CDXC.US)$ 👀looks like finally topped